Adelaide BioMed City announces a new Board

02 September 2022

Now in its fourth year of operation, Adelaide Biomed City is entering a new phase of development as a catalyst improving commercial outcomes from South Australia’s investment in health and medical research and associated infrastructure. 

Through its new strategic plan, ABMC is focussing on helping collaborations within SA, with industry partners and emphasising SA’s strength in clinical trials and combining new technologies.

Adelaide Biomed City have formally announced their new independent skills-based Board, who have extensive experience across commercialisation, clinical development, strategic marketing, entrepreneurship and community engagement - an incredible team to lead a new phase of development!

MTPConnect's team in South Australia, led by Jo Close, is fortunate to work with them as an intermediary, building connections and opportunities.

Find out more about the Board and Adelaide Biomed City's direction here